Standard BioTools stockholders approve Treeline merger and sale of Mass Cytometry business
FROM THE WIRE · GLOBENEWSWIRE.COM
BOSTON, Mass., Nov. 19, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced that, at its Special Meeting of Stockholders held earlier today, stockholders approved all proposals related to the Company's previously…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralShareholder approval clears a merger and a divestiture that matter for the LAB stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Standard BioTools stockholders approved all proposals related to the merger with Treeline Biosciences.
- 02The sale of the Mass Cytometry business to Element Biosystems, backed by GMT Venture Partners, was also approved.
- 03The decision was taken at the Special Meeting of Stockholders held today.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets